Longeveron Company
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. This is through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors. The Longeveron-grown Mesenchymal Stem Cell (LMSCs) product is manufactured in Longeveron’s cell processing facility located in Miami, Florida.
Technology:
Regenerative Medicine
Industry:
Cellular therapy
Headquarters:
Miami, Florida, United States
Founded Date:
11/1/2014
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
3
Total Funding:
$9M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership